Global Primary Care Point of Care (POC) Diagnostics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Product;
Primary care POC glucose testing, Hb1Ac testing, POC coagulation testing, POC fertility testing and Primary Care POC infectious diseases testing - HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory Syncytial Virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, HSV POC, TB and drug-resistant TB POC and Other infectious diseases, POC cardiac markers, POC thyroid testing, Hematology POC testing, Primary care systems, Decentralized clinical chemistry POC testing, Feces POC testing, Lipid POC, Primary care POC cancer marker, Blood gas/electrolytes POC, Ambulatory chemistry POC, Drug abuse POC testing and Urinalysis POC testing.Segmented by End Use;
Pharmacy & retail clinics, Physician office, Urgent care clinics and Non-practice clinics.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Primary Care Point of Care (POC) Diagnostics Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 81.1 |
2021 | 91.8 |
2022 | 108.5 |
2023 | 110.9 |
2024 | 122.1 |
2025 | 132.6 |
2026 | 155.9 |
2027 | 166.9 |
2028 | 188.4 |
2029 | 216.5 |
2030 | 228.0 |
In the year 2023, the Global Primary Care Point of Care (POC) Diagnostics Market was valued at USD 7,336.31 million. The size of this market is expected to increase to USD 9,283.45 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 3.4%.
Global Primary Care Point of Care (POC) Diagnostics Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Primary Care Point of Care (POC) Diagnostics Market |
Study Period | 2020 - 2030 |
Base Year (for Primary Care Point of Care (POC) Diagnostics Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Primary Care Point of Care (POC) Diagnostics Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Primary Care Point of Care (POC) Diagnostics Market Analysis
In this report, the Global Primary Care Point of Care (POC) Diagnostics Market has been segmented by Product, End Use and Geography.
Global Primary Care Point of Care (POC) Diagnostics Market, Segmentation by Product
The Global Primary Care Point of Care (POC) Diagnostics Market has been segmented by Product into Primary care POC glucose testing, Hb1Ac testing, POC coagulation testing, POC fertility testing, Primary Care POC infectious diseases testing, POC cardiac markers, POC thyroid testing, Hematology POC testing, Primary care systems, Decentralized clinical chemistry POC testing, Feces POC testing, Lipid POC, Primary care POC cancer marker, Blood gas/electrolytes POC, Ambulatory chemistry POC, Drug abuse POC testing and Urinalysis POC testing. The complete Global Primary Care Point of Care (POC) Diagnostics Market segmentation by Product can be seen below:
- Global Primary Care Point of Care (POC) Diagnostics Market, By Product
- Primary care POC glucose testing
- Hb1Ac testing
- POC coagulation testing
- POC fertility testing
- Primary Care POC infectious diseases testing
- HIV POC
- Clostridium difficile POC
- HBV POC
- Pneumonia or Streptococcus associated infections
- Respiratory Syncytial Virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- HSV POC
- TB and drug-resistant TB POC
- Other infectious diseases
- POC cardiac markers
- POC thyroid testing
- Hematology POC testing
- Primary care systems
- Decentralized clinical chemistry POC testing
- Feces POC testing
- Lipid POC
- Primary care POC cancer marker
- Blood gas/electrolytes POC
- Ambulatory chemistry POC
- Drug abuse POC testing
- Urinalysis POC testing
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Products mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Product is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Primary Care Point of Care (POC) Diagnostics Market, by Product (USD Million), 2020 - 2030
# | Primary care POC glucose testing | Hb1Ac testing | POC coagulation testing | POC fertility testing | Primary Care POC infectious diseases testing | POC cardiac markers | POC thyroid testing | Hematology POC testing | Primary care systems | Decentralized clinical chemistry POC testing | Feces POC testing | Lipid POC | Primary care POC cancer marker | Blood gas/electrolytes POC | Ambulatory chemistry POC | Drug abuse POC testing | Urinalysis POC testing |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2020 | 106.0 | 79.1 | 69.3 | 62.8 | 65.8 | 79.2 | 73.8 | 82.5 | 102.7 | 71.1 | 83.5 | 64.7 | 103.6 | 74.2 | 79.2 | 63.8 | 61.9 |
2021 | 111.1 | 82.8 | 81.4 | 68.6 | 77.3 | 80.8 | 83.4 | 85.9 | 107.0 | 82.1 | 94.0 | 65.5 | 108.6 | 82.8 | 81.8 | 76.1 | 64.9 |
2022 | 121.1 | 89.0 | 86.1 | 69.8 | 83.6 | 81.1 | 97.8 | 90.5 | 111.4 | 82.4 | 95.6 | 77.2 | 119.2 | 96.0 | 96.5 | 83.7 | 71.9 |
2023 | 131.3 | 96.4 | 97.6 | 77.9 | 85.5 | 91.1 | 111.5 | 91.4 | 132.2 | 91.6 | 111.3 | 88.2 | 131.5 | 104.8 | 107.7 | 92.8 | 77.3 |
2024 | 156.0 | 96.8 | 116.2 | 80.9 | 99.9 | 108.8 | 124.5 | 99.9 | 155.8 | 102.7 | 122.3 | 97.3 | 151.2 | 119.6 | 113.1 | 95.2 | 80.4 |
2025 | 168.9 | 113.9 | 138.9 | 82.4 | 114.6 | 111.1 | 145.0 | 103.9 | 181.9 | 122.8 | 131.4 | 111.9 | 175.6 | 125.3 | 119.5 | 98.4 | 84.3 |
2026 | 201.6 | 122.9 | 157.5 | 95.1 | 126.4 | 130.9 | 167.4 | 123.8 | 211.7 | 130.5 | 135.7 | 115.2 | 179.1 | 149.9 | 120.6 | 107.4 | 84.6 |
2027 | 228.0 | 135.0 | 179.3 | 110.8 | 141.9 | 149.7 | 168.0 | 139.4 | 236.6 | 144.1 | 144.3 | 122.7 | 191.4 | 162.2 | 144.3 | 117.1 | 99.7 |
2028 | 259.0 | 138.9 | 182.0 | 127.8 | 167.9 | 166.7 | 196.8 | 160.1 | 248.9 | 151.4 | 155.8 | 125.0 | 218.9 | 172.6 | 151.6 | 118.8 | 116.2 |
2029 | 299.6 | 155.9 | 187.6 | 146.5 | 169.7 | 176.3 | 216.7 | 175.5 | 284.6 | 155.0 | 176.3 | 133.6 | 249.7 | 194.6 | 172.1 | 131.6 | 130.9 |
2030 | 302.0 | 186.0 | 189.8 | 154.8 | 195.1 | 176.9 | 219.9 | 187.0 | 313.4 | 159.6 | 202.2 | 141.6 | 275.7 | 201.1 | 203.2 | 139.1 | 147.1 |
Global Primary Care Point of Care (POC) Diagnostics Market, Segmentation by End Use
The Global Primary Care Point of Care (POC) Diagnostics Market has been segmented by End Use into Pharmacy & retail clinics, Physician office, Urgent care clinics and Non-practice clinics. The complete Global Primary Care Point of Care (POC) Diagnostics Market segmentation by End Use can be seen below:
- Global Primary Care Point of Care (POC) Diagnostics Market, By End Use
- Pharmacy & retail clinics
- Physician office
- Urgent care clinics
- Non-practice clinics
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the End Uses mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by End Use is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Primary Care Point of Care (POC) Diagnostics Market, by End Use (USD Million), 2020 - 2030
# | Pharmacy & retail clinics | Physician office | Urgent care clinics | Non-practice clinics |
---|---|---|---|---|
2020 | 73.0 | 101.0 | 107.6 | 77.7 |
2021 | 82.7 | 114.4 | 117.6 | 87.6 |
2022 | 89.1 | 116.7 | 139.6 | 97.2 |
2023 | 95.4 | 116.8 | 161.6 | 111.8 |
2024 | 104.6 | 132.2 | 179.8 | 118.2 |
2025 | 124.3 | 142.4 | 201.7 | 133.9 |
2026 | 146.1 | 170.3 | 234.4 | 134.3 |
2027 | 149.8 | 181.4 | 242.5 | 143.0 |
2028 | 156.4 | 188.2 | 276.6 | 149.8 |
2029 | 175.6 | 196.5 | 326.5 | 170.5 |
2030 | 199.3 | 198.4 | 368.6 | 180.1 |
Global Primary Care Point of Care (POC) Diagnostics Market, Segmentation by Geography
In this report, the Global Primary Care Point of Care (POC) Diagnostics Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Primary Care Point of Care (POC) Diagnostics Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Primary Care Point of Care (POC) Diagnostics Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Primary Care Point of Care (POC) Diagnostics in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Primary Care Point of Care (POC) Diagnostics Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The growth of the Global Primary Care Point of Care (POC) Diagnostics Market is driven by; Increasing adoption as well as accessibility of Point-of-Care Testing (POCT) in primary care settings, Rapid advances in POCT for primary care settings and Surveys and studies demonstrating POCT for primary care settings & consequent enhanced adoption rate in primary care.
- While the growth of Global Primary Care Point of Care (POC) Diagnostics Market is currently hindered by; High procedure costs coupled with limited adoption of POC devices in certain emerging regions and Presence of ambiguous regulatory as well as reimbursement framework for primary care setting.
- The new opportunities in Global Primary Care Point of Care (POC) Diagnostics Market will be discussed in detail in the full report.
- Increasing adoption as well as accessibility of Point-of-Care Testing (POCT) in primary care settings.
- Rapid advances in POCT for primary care settings.
- Surveys and studies demonstrating POCT for primary care settings & consequent enhanced adoption rate in primary care.
- High procedure costs coupled with limited adoption of POC devices in certain emerging regions.
- Presence of ambiguous regulatory as well as reimbursement framework for primary care setting.
- Global Primary Care Point of Care (POC) Diagnostics Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Primary Care Point of Care (POC) Diagnostics Market. The opportunity map (by market segments; Product and End Use) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Primary Care Point of Care (POC) Diagnostics Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Primary Care Point of Care (POC) Diagnostics Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Primary Care Point of Care (POC) Diagnostics Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Primary Care Point of Care (POC) Diagnostics Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value. India's older people are one of the groups that home healthcare companies and the overall (point of care market research) poct market in point-of-care infectious disease diagnostics market are trying to reach.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Primary Care Point of Care (POC) Diagnostics Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Primary Care Point of Care (POC) Diagnostics Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Primary Care Point of Care (POC) Diagnostics Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Primary Care Point of Care (POC) Diagnostics Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Primary Care Point of Care (POC) Diagnostics Market include, F Hoffmann-La Roche Ltd., Danaher, Abbott, Siemens Healthineers, bioMerieux SA, Abaxis, QIAGEN, Johnson & Johnson Services, Inc., Nova Biomedical and Trividia Health.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By End Use
- Market Snapshot, By Region
- Market Opportunity Map
- Global Primary Care Point of Care (POC) Diagnostics Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing adoption as well as accessibility of Point-of-Care Testing (POCT) in primary care settings
- Rapid advances in POCT for primary care settings
- Surveys and studies demonstrating POCT for primary care settings & consequent enhanced adoption rate in primary care
- Restraints
- High procedure costs coupled with limited adoption of POC devices in certain emerging regions
- Presence of ambiguous regulatory as well as reimbursement framework for primary care setting
- Opportunities
- Drivers
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Primary Care Point of Care (POC) Diagnostics Market, By Product, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Primary care POC glucose testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Hb1Ac testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- POC coagulation testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- POC fertility testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Primary Care POC infectious diseases testing
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- HIV POC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Clostridium difficile POC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- HBV POC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Pneumonia or Streptococcus associated infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Respiratory Syncytial Virus (RSV) POC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- HPV POC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Influenza/Flu POC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- HCV POC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- MRSA POC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- HSV POC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- TB and drug-resistant TB POC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Other infectious diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- HIV POC
- POC cardiac markers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- POC thyroid testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Hematology POC testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Primary care systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Decentralized clinical chemistry POC testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Feces POC testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Lipid POC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Primary care POC cancer marker
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Blood gas/electrolytes POC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Ambulatory chemistry POC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Drug abuse POC testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Urinalysis POC testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Primary care POC glucose testing
- Global Primary Care Point of Care (POC) Diagnostics Market, By End Use, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Pharmacy & retail clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Physician office
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Urgent care clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Non-practice clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Pharmacy & retail clinics
- Global Primary Care Point of Care (POC) Diagnostics Market, By Geography, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Japan
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- GCC
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Brazil
- North America
- Global Primary Care Point of Care (POC) Diagnostics Market, By Product, 2020 - 2030 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- F Hoffmann-La Roche Ltd.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Danaher
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Abbott
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Siemens Healthineers
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- bioMerieux SA
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Abaxis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- QIAGEN
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Johnson & Johnson Services, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Nova Biomedical
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Trividia Health, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- F Hoffmann-La Roche Ltd.
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Primary Cell Culture Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Primary Cells Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Primary Sclerosing Cholangitis Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Proliferative Diabetic Retinopathy Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%